# A Study of Monthly Subcutaneous or Intravenous Mircera in Dialysis Patients With Chronic Renal Anaemia

> **NCT01156363** · PHASE4 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 86 (actual)

## Conditions studied

- Anemia

## Interventions

- **PROCEDURE:** Dialysis
- **DRUG:** methoxy polyethylene glycol-epoetin beta [Mircera]

## Key facts

- **NCT ID:** NCT01156363
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-10
- **Primary completion:** 2013-01
- **Final completion:** 2013-01
- **Target enrollment:** 86 (ACTUAL)
- **Last updated:** 2015-12-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01156363

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01156363, "A Study of Monthly Subcutaneous or Intravenous Mircera in Dialysis Patients With Chronic Renal Anaemia". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT01156363. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*